Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Q-Line Biotech Ltd. Share Price
Day's Range
Low
₹509.55
High
₹538.00
Price Summary
| Previous Close | ₹512.75 |
|---|---|
| Day's Range | ₹509.55 - ₹538.00 |
| Open | ₹538.00 |
| 52 Week Range | ₹431.00 - ₹735.00 |
| Volume | 66,800 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 348.63 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 21.47 |
| TTM EPS (₹) | 23.89 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 2.45 |
| PAT Margin (%) | 15.41 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 22.23 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 3131.44 |
| Expenses | N/A | N/A |
| PBT | N/A | 382.67 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 192.11 |
About Q-Line Biotech Ltd.
| Founded | 2010 |
|---|---|
| Managing Director | Saurabh Garg |
| NSE Symbol | QLINE |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,26,661.74 | 1,778.25 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,57,902.73 | 9,715.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,76,306.21 | 4,635.15 | 3,532.60 - 3,532.60 |
| Laurus Labs Ltd. | 1,29,242.68 | 2,392.00 | 917.95 - 917.95 |
| Zydus Lifesciences Ltd. | 1,24,089.48 | 1,244.00 | 835.50 - 835.50 |
| Apollo Hospitals Enterprise Ltd. | 1,20,779.11 | 8,400.00 | 6,696.50 - 6,696.50 |
| Lenskart Solutions Ltd. | 1,17,959.74 | 678.20 | 0.00 - 0.00 |
| Dr. Reddy's Laboratories Ltd. | 1,12,698.53 | 1,350.20 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,11,488.55 | 1,380.00 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,02,796.60 | 2,488.75 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
RainbowChildrenS Med - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 4869.91 | 4084.96 | 19.22 | 8975.38 | 7432.44 | 20.76 | 15456.60 | 14545.06 | 6.27 |
| Other Income | 80.92 | 81.73 | -0.99 | 208.49 | 274.58 | -24.07 | 434.54 | 489.49 | -11.23 |
| PBIDT | 1595.88 | 1488.91 | 7.18 | 2870.04 | 2676.97 | 7.21 | 5433.11 | 5234.23 | 3.80 |
| Interest | 199.14 | 173.09 | 15.05 | 391.63 | 347.02 | 12.86 | 713.96 | 695.94 | 2.59 |
| PBDT | 1396.74 | 1315.82 | 6.15 | 2478.41 | 2329.95 | 6.37 | 4703.76 | 4538.29 | 3.65 |
| Depreciation | 398.09 | 331.82 | 19.97 | 774.35 | 657.75 | 17.73 | 1362.61 | 1317.48 | 3.43 |
| PBT | 998.65 | 984.00 | 1.49 | 1704.06 | 1672.20 | 1.91 | 3341.15 | 3220.81 | 3.74 |
| TAX | 247.72 | 252.33 | -1.83 | 426.07 | 423.33 | 0.65 | 840.99 | 844.98 | -0.47 |
| Deferred Tax | -57.47 | -27.87 | 106.21 | -68.71 | -22.06 | 211.47 | -73.38 | -31.54 | 132.66 |
| PAT | 750.93 | 731.67 | 2.63 | 1277.99 | 1248.87 | 2.33 | 2500.16 | 2375.83 | 5.23 |
| Equity | 1015.66 | 1015.59 | 0.01 | 1015.66 | 1015.59 | 0.01 | 1015.59 | 1015.52 | 0.01 |
| PBIDTM(%) | 32.77 | 36.45 | -10.09 | 31.98 | 36.02 | -11.22 | 35.15 | 35.99 | -2.32 |
Shree Ganesh Remed. - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 232.95 | 303.15 | -23.16 | 376.55 | 549.83 | -31.52 | 1092.86 | 1085.96 | 0.64 |
| Other Income | 14.06 | 6.90 | 103.77 | 23.45 | 13.52 | 73.45 | 30.30 | 37.30 | -18.77 |
| PBIDT | 53.42 | 103.09 | -48.18 | 96.34 | 182.68 | -47.26 | 380.50 | 429.42 | -11.39 |
| Interest | 5.75 | 10.10 | -43.07 | 8.94 | 19.50 | -54.15 | 35.62 | 20.77 | 71.50 |
| PBDT | 47.67 | 92.99 | -48.74 | 87.40 | 163.18 | -46.44 | 344.88 | 408.65 | -15.61 |
| Depreciation | 25.03 | 25.87 | -3.25 | 49.44 | 50.07 | -1.26 | 104.73 | 95.67 | 9.47 |
| PBT | 22.64 | 67.12 | -66.27 | 37.96 | 113.11 | -66.44 | 240.15 | 312.98 | -23.27 |
| TAX | 6.29 | 17.55 | -64.16 | 10.40 | 29.04 | -64.19 | 62.42 | 81.99 | -23.87 |
| Deferred Tax | 0.58 | 2.17 | -73.27 | 1.23 | 3.47 | -64.55 | 5.33 | -0.45 | -1284.44 |
| PAT | 16.35 | 49.57 | -67.02 | 27.56 | 84.07 | -67.22 | 177.73 | 230.99 | -23.06 |
| Equity | 128.38 | 128.38 | 0.00 | 128.38 | 128.38 | 0.00 | 128.38 | 128.38 | 0.00 |
| PBIDTM(%) | 22.93 | 34.01 | -32.57 | 25.58 | 33.22 | -22.99 | 34.82 | 39.54 | -11.95 |
Unick Fix-A-Form - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 131.42 | 147.84 | -11.11 | 318.20 | 319.34 | -0.36 | 589.07 | 559.79 | 5.23 |
| Other Income | 0.97 | 0.56 | 73.21 | 0.98 | 0.78 | 25.64 | 3.88 | 1.76 | 120.45 |
| PBIDT | 19.33 | 18.21 | 6.15 | 49.19 | 49.70 | -1.03 | 71.19 | 91.40 | -22.11 |
| Interest | 4.37 | 5.27 | -17.08 | 9.78 | 12.89 | -24.13 | 23.68 | 20.66 | 14.62 |
| PBDT | 14.96 | 12.94 | 15.61 | 39.41 | 36.81 | 7.06 | 47.51 | 70.74 | -32.84 |
| Depreciation | 9.67 | 9.02 | 7.21 | 19.25 | 17.84 | 7.90 | 36.20 | 35.60 | 1.69 |
| PBT | 5.29 | 3.92 | 34.95 | 20.16 | 18.97 | 6.27 | 11.31 | 35.14 | -67.81 |
| TAX | 1.12 | -1.12 | -200.00 | 4.92 | 2.70 | 82.22 | 2.79 | 9.04 | -69.14 |
| Deferred Tax | -0.18 | -2.12 | -91.51 | -0.10 | -2.05 | -95.12 | 0.39 | -4.55 | -108.57 |
| PAT | 4.17 | 5.04 | -17.26 | 15.24 | 16.27 | -6.33 | 8.52 | 26.10 | -67.36 |
| Equity | 54.85 | 54.85 | 0.00 | 54.85 | 54.85 | 0.00 | 54.85 | 54.85 | 0.00 |
| PBIDTM(%) | 14.71 | 12.32 | 19.41 | 15.46 | 15.56 | -0.67 | 12.09 | 16.33 | -25.98 |
Emmessar Biotech&Nut - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 1.09 | 0.92 | 18.48 | 1.68 | 1.85 | -9.19 | 3.71 | 6.11 | -39.28 |
| Other Income | 5.16 | 5.39 | -4.27 | 10.55 | 10.73 | -1.68 | 20.36 | 20.09 | 1.34 |
| PBIDT | 1.96 | 1.65 | 18.79 | 3.82 | 4.22 | -9.48 | 6.83 | 10.58 | -35.44 |
| Interest | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.00 | 0.02 | 0.01 | 100.00 |
| PBDT | 1.95 | 1.64 | 18.90 | 3.80 | 4.20 | -9.52 | 6.81 | 10.57 | -35.57 |
| Depreciation | 0.23 | 0.25 | -8.00 | 0.46 | 0.50 | -8.00 | 1.00 | 0.98 | 2.04 |
| PBT | 1.72 | 1.39 | 23.74 | 3.34 | 3.70 | -9.73 | 5.81 | 9.59 | -39.42 |
| TAX | 0.32 | 0.26 | 23.08 | 0.64 | 0.86 | -25.58 | 1.44 | 6.42 | -77.57 |
| Deferred Tax | -0.11 | -0.10 | 10.00 | -0.20 | -0.10 | 100.00 | -0.37 | 2.02 | -118.32 |
| PAT | 1.40 | 1.13 | 23.89 | 2.70 | 2.84 | -4.93 | 4.37 | 3.17 | 37.85 |
| Equity | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 |
| PBIDTM(%) | 179.82 | 179.35 | 0.26 | 227.38 | 228.11 | -0.32 | 184.10 | 173.16 | 6.32 |
Advanced Enzyme Tech - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 1371.68 | 1157.48 | 18.51 | 2530.25 | 2407.72 | 5.09 | 4527.66 | 3514.11 | 28.84 |
| Other Income | 163.97 | 30.79 | 432.54 | 186.84 | 569.31 | -67.18 | 633.88 | 614.90 | 3.09 |
| PBIDT | 543.16 | 326.70 | 66.26 | 870.15 | 1170.48 | -25.66 | 1738.22 | 1321.69 | 31.51 |
| Interest | 0.31 | 0.49 | -36.73 | 0.68 | 1.02 | -33.33 | 2.07 | 2.36 | -12.29 |
| PBDT | 542.85 | 326.21 | 66.41 | 869.47 | 1169.46 | -25.65 | 1697.57 | 1319.33 | 28.67 |
| Depreciation | 31.73 | 30.02 | 5.70 | 60.94 | 59.31 | 2.75 | 120.83 | 114.05 | 5.94 |
| PBT | 511.12 | 296.19 | 72.56 | 808.53 | 1110.15 | -27.17 | 1576.74 | 1205.28 | 30.82 |
| TAX | 94.07 | 73.37 | 28.21 | 168.02 | 147.52 | 13.90 | 258.68 | 181.08 | 42.85 |
| Deferred Tax | 1.25 | 0.54 | 131.48 | 8.56 | 0.28 | 2957.14 | -12.01 | 12.22 | -198.28 |
| PAT | 417.05 | 222.82 | 87.17 | 640.51 | 962.63 | -33.46 | 1318.06 | 1024.20 | 28.69 |
| Equity | 220.53 | 223.76 | -1.44 | 223.95 | 223.76 | 0.08 | 223.85 | 223.76 | 0.04 |
| PBIDTM(%) | 39.60 | 28.23 | 40.29 | 34.39 | 48.61 | -29.26 | 38.39 | 37.61 | 2.07 |
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Q-Line Biotech Ltd. is ₹512.75 as of 2026-10-30.
The market capitalisation of Q-Line Biotech Ltd. is ₹1,196.15 as of 2026-10-30.
The 1-year return of Q-Line Biotech Ltd. is % as of .
The P/E ratio of Q-Line Biotech Ltd. is 0.00 as of 2026-11-01.
The 52-week high and low of Q-Line Biotech Ltd. are ₹735.00 and ₹431.00, respectively, as of 2026-10-30.
People Also Ask
Q-Line Biotech Ltd. is an Indian healthcare company engaged in developing, manufacturing and marketing diagnostic reagents, kits, point-of-care devices and consumables, as well as manufacturing, importing, distributing and supplying diagnostic equipment.
The company supplies diagnostic equipment, reagents, testing kits and consumables to hospitals, medical colleges, laboratories and diagnostic service providers.
Q-Line Biotech Ltd. was originally incorporated as POCT Services Private Limited on 10 November 2010. Its name was changed to Q-Line Biotech Private Limited in 2021. In February 2025, shareholders approved its conversion from a private limited company to a public limited company, and a fresh certificate of incorporation was issued on 8 March 2025, reflecting the name Q-Line Biotech Limited.
Q-Line Biotech operates in the healthcare and in-vitro diagnostics industry. Its activities cover clinical chemistry, haematology, immunodiagnostics, molecular diagnostics and point-of-care testing.
Its portfolio includes diagnostic reagents, testing kits, point-of-care devices, analysers, laboratory equipment and related consumables. The company also distributes and services diagnostic equipment.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
